Aardvark Therapeutics to Present at Upcoming Investor Conferences in May
Provided By GlobeNewswire
Last update: May 7, 2025
SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, announced that it will present at the following conferences during May:
Read more at globenewswire.com
